======= TMEM8C =======
== Gene Information ==
* **Official Symbol**: MYMK
* **Official Name**: myomaker, myoblast fusion factor
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=389827|389827]]
* **UniProt**: [[https://www.uniprot.org/uniprot/A6NI61|A6NI61]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TMEM8C&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TMEM8C|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/615345|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Myoblast-specific protein that mediates myoblast fusion, an essential step for the formation of multi-nucleated muscle fibers. Actively participates in the membrane fusion reaction. Associates with MYMX to promote myoblast fusion. {ECO:0000269|PubMed:28681861}.
|DUF3522|
|positive regulation of skeletal muscle hypertrophy|
|regulation of skeletal muscle hypertrophy|
|myoblast fusion involved in skeletal muscle regeneration|
|positive regulation of muscle adaptation|
|myotube differentiation involved in skeletal muscle regeneration|
|regulation of skeletal muscle adaptation|
|plasma membrane fusion|
|myoblast fusion|
|positive regulation of muscle hypertrophy|
|skeletal muscle tissue regeneration|
|cell-cell fusion|
|syncytium formation by plasma membrane fusion|
|syncytium formation|
|myotube differentiation|
|regulation of muscle hypertrophy|
|integral component of Golgi membrane|
|tissue regeneration|
|regulation of muscle adaptation|
|membrane fusion|
|regeneration|
|striated muscle cell differentiation|
|regulation of muscle system process|
|muscle cell differentiation|
|muscle organ development|
|developmental growth|
|growth|
|muscle structure development|
|wound healing|
|response to wounding|
|regulation of system process|
|membrane organization|
|anatomical structure formation involved in morphogenesis|
|integral component of plasma membrane|
|positive regulation of multicellular organismal process|
|tissue development|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|1.72|
|[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|1.79|
|[[:results:exp456|Benzoate 20000μM R08 exp456]]|2.03|
|[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|2.38|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9804
* **Expression level (log2 read counts)**: -2.51
{{:chemogenomics:nalm6 dist.png?nolink |}}